Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS - PubMed (original) (raw)
Comparative Study
doi: 10.4161/cc.3.11.1211. Epub 2004 Nov 8.
Affiliations
- PMID: 15492509
- DOI: 10.4161/cc.3.11.1211
Comparative Study
Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS
Magdalene K Sgagias et al. Cell Cycle. 2004 Nov.
Abstract
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(fl/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1(-/-) MMECs were generated by deletion of exon 11 following transduction of Brca1(fl/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride (CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECS is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays out in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
Similar articles
- Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.
Alli E, Sharma VB, Hartman AR, Lin PS, McPherson L, Ford JM. Alli E, et al. BMC Pharmacol. 2011 Jul 19;11:7. doi: 10.1186/1471-2210-11-7. BMC Pharmacol. 2011. PMID: 21771338 Free PMC article. - Brca1 regulates in vitro differentiation of mammary epithelial cells.
Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschläger M. Kubista M, et al. Oncogene. 2002 Jul 18;21(31):4747-56. doi: 10.1038/sj.onc.1205580. Oncogene. 2002. PMID: 12101413 - Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.
Muraoka-Cook RS, Caskey LS, Sandahl MA, Hunter DM, Husted C, Strunk KE, Sartor CI, Rearick WA Jr, McCall W, Sgagias MK, Cowan KH, Earp HS 3rd. Muraoka-Cook RS, et al. Mol Cell Biol. 2006 Sep;26(17):6412-24. doi: 10.1128/MCB.01950-05. Mol Cell Biol. 2006. PMID: 16914727 Free PMC article. - Tumor formation in Brca1 conditional mutant mice.
Deng CX. Deng CX. Environ Mol Mutagen. 2002;39(2-3):171-7. doi: 10.1002/em.10069. Environ Mol Mutagen. 2002. PMID: 11921186 Review. - The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
Moynahan ME. Moynahan ME. Oncogene. 2002 Dec 16;21(58):8994-9007. doi: 10.1038/sj.onc.1206177. Oncogene. 2002. PMID: 12483515 Review.
Cited by
- Role of Epigenetics for the Efficacy of Cisplatin.
Lumpp T, Stößer S, Fischer F, Hartwig A, Köberle B. Lumpp T, et al. Int J Mol Sci. 2024 Jan 17;25(2):1130. doi: 10.3390/ijms25021130. Int J Mol Sci. 2024. PMID: 38256203 Free PMC article. Review. - Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".
Cantor SB. Cantor SB. DNA Repair (Amst). 2021 Nov;107:103209. doi: 10.1016/j.dnarep.2021.103209. Epub 2021 Aug 13. DNA Repair (Amst). 2021. PMID: 34419699 Free PMC article. Review. - Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K, Peng M, Kousholt AN, Lee WTC, Lee S, Nayak S, Krais J, VanderVere-Carozza PS, Pawelczak KS, Calvo J, Panzarino NJ, Turchi JJ, Johnson N, Jonkers J, Rothenberg E, Cantor SB. Cong K, et al. Mol Cell. 2021 Aug 5;81(15):3128-3144.e7. doi: 10.1016/j.molcel.2021.06.011. Epub 2021 Jul 2. Mol Cell. 2021. PMID: 34216544 Free PMC article. - Influence of Kv11.1 (hERG1) K+ channel expression on DNA damage induced by the genotoxic agent methyl methanesulfonate.
Fernández-Villabrille S, Álvarez-González E, Barros F, de la Peña P, Sierra LM. Fernández-Villabrille S, et al. Pflugers Arch. 2021 Feb;473(2):197-217. doi: 10.1007/s00424-021-02517-2. Epub 2021 Jan 15. Pflugers Arch. 2021. PMID: 33452554 - USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q, Zhang FL, Lu DY, Shao ZM, Li DQ. Lu Q, et al. Cancer Med. 2019 Nov;8(15):6730-6740. doi: 10.1002/cam4.2528. Epub 2019 Sep 11. Cancer Med. 2019. PMID: 31512408 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous